Related Experiment Video
Updated: Jan 6, 2026

12:16
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
21.7K
Merkel cell carcinoma with divergent differentiation
K Gaitskell1, S Nassar2, H Ibrahim1,3
1Department of Cellular Pathology, Royal Free Hospital, London, UK.
Clinical and Experimental Dermatology
|October 4, 2019
Summary
Merkel cell carcinoma (MCC), a rare skin cancer, can exhibit divergent differentiation into squamous or adnexal types. Recognizing this is crucial, as recurrences may solely display the Merkel cell component.
Area of Science:
- Dermatology
- Pathology
- Oncology
Background:
- Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer primarily affecting elderly individuals on sun-exposed skin.
- While rare, divergent differentiation in MCC has been previously documented in case series.
Observation:
- Two new cases of MCC with divergent differentiation are presented.
- Case 1: A 96-year-old male with a scalp lesion showed MCC with divergent squamous differentiation.
- Case 2: An 87-year-old female with a leg lesion initially diagnosed as squamous cell carcinoma was found to have MCC with divergent differentiation (likely trichilemmal carcinoma); recurrence showed only MCC.
Findings:
- These cases confirm that MCC can differentiate into squamous and adnexal morphologies.
- The divergent differentiation can complicate initial diagnosis, with subsequent recurrences potentially losing the divergent features.
Implications:
- Accurate diagnosis of MCC with divergent differentiation is critical for appropriate patient prognosis and management.
- Delayed or incorrect diagnosis can lead to inadequate treatment, as metastatic or recurrent disease may present solely as MCC.
Related Concept Videos
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K

